Tech Company Financing Transactions
Aeolus Pharmaceuticals Funding Round
Aeolus Pharmaceuticals, based in Mission Viejo, received $690.1 thousand in investment from private investors.
Transaction Overview
Company Name
Announced On
4/19/2012
Transaction Type
Venture Equity
Amount
$690,050
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
26361 Crown Valley Pkwy. 150
Mission Viejo, CA 92691
USA
Mission Viejo, CA 92691
USA
Phone
Website
Email Address
Not Recorded
Overview
Aeolous Pharmaceuticals (OTC BB: AOLS) is a biopharmaceutical company that is developing a new class of catalytic antioxidant compunds, referred to as manganoporphyrins, for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John McManus
Chief Financial Officer
David Cavalier
Chief Scientific Officer
Brian Day
VP - Operations
Christopher Stanley
Browse more venture capital transactions:
Prev: 4/19/2012: Big Fish Games venture capital transaction
Next: 4/19/2012: Coursera venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs